How To Select The Right Biologics CDMO Partner

By Abby Sorensen, Marketing Manager, Scorpius BioManufacturing

When selecting a biologics contract development and manufacturing organization (CDMO) partner—whether you need mammalian or microbial capabilities—the decision-making process follows a similar process. As discussed in "Evaluating Biologics CDMOs: Tips for Crafting an RFP," your ultimate goal is selecting a partner that can manufacture product of consistent quality at the needed scale, within your allocated budget, and in your required timeline.

To simplify this complex decision-making process as much as possible, it helps to segment essential and strategic CDMO partner characteristics. These essential capabilities and organizational traits are non-negotiable, as they are necessary to achieve the ultimate goal of releasing an FDA-approved therapeutic to the market.